HAT-seq Method for Somatic Transposon Insertion Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods face challenges in identifying and distinguishing de novo somatic transposition events due to high background noise from abundant germline transposons, leading to low detection accuracy and inability to characterize these events effectively.

Innovation Solution

The Human Active Transposon sequencing (HAT-seq) method involves fragmenting genomic DNA, ligating adaptors, and using specific primers to enrich transposon sequences, followed by high-throughput sequencing and bioinformatics analysis to accurately determine the genomic location and orientation of transposons, allowing for the differentiation and quantification of de novo insertions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional sequencing methods are used to detect transposon insertions, then germline transposons can be detected, but de novo somatic transposition events cannot be distinguished due to high background noise

Engineering Contradiction:
Improvedetection accuracyVSAvoidbackground noise
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The method extracts and removes germline transposon sequences from the sequencing data through in silico subtraction using a comprehensive germline transposon database. This extraction of the harmful background noise allows the rare de novo somatic insertion signals to be clearly identified without interference from the abundant germline transposons.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The method performs preliminary actions by constructing a comprehensive germline transposon database before sequencing and pre-enriching transposon-containing DNA fragments through targeted PCR amplification using transposon-specific primers. These preliminary steps prepare the data for accurate differentiation of de novo insertions by establishing a reference framework and concentrating the relevant signals.

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If high-throughput sequencing is used to detect low frequency somatic mutations, then detection sensitivity is improved, but the ability to distinguish de novo insertions from germline insertions deteriorates due to sequence similarity

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsequence specificity
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The method introduces an intermediary approach by using paired-end sequencing to capture flanking sequences adjacent to transposon insertions. These flanking sequences serve as unique identifiers that mediate the distinction between de novo and germline insertions, since the flanking genomic context differs even when the transposon sequences themselves are identical.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The method transitions from analyzing only the one-dimensional transposon sequence to incorporating the dimensional context of flanking sequences. By examining the genomic region surrounding the insertion site in addition to the transposon sequence itself, the method creates a multi-dimensional signature that enables accurate classification of insertion types despite sequence similarity.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Measurement precision

If conventional methods are used for transposon detection, then abundant germline transposons are detected, but the low frequency de novo insertions are lost in the background

Engineering Contradiction:
Improvedetection accuracyVSAvoidsignal to noise ratio
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The method implements feedback by using the detected insertion positions and flanking sequences to iteratively refine the identification of de novo insertions. The system compares detected insertions against the germline database and uses the results to adjust and improve detection accuracy, ensuring that rare de novo events are not lost in the background of abundant germline transposons.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS12077814B2Method for low frequency somatic cell mutation identification and quantification
Publication Date: 2024.09.03 PEKING UNIV
  • US12077814B2 patent drawing
  • US12077814B2 patent drawing
  • US12077814B2 patent drawing

AI summary

A method for low frequency somatic cell mutation identification and quantification, relating specifically to a method for transposon copy number and genome location identification. Specific sites of different transposon families are used, transposon insertion sequences are specifically enriched via library construction, high-throughput sequencing and bioinformatics analysis are used, and genome locations, copy numbers and types of transposons within samples are accurately identified. The method economically and accurately identifies copy numbers and genome locations of transposons.